We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SLSN:NASDAQSolesence, Inc. Analysis

Data as of 2026-06-13 - not real-time

$1.33

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Solesence, Inc. (SLSN) is trading at a **price‑to‑earnings ratio of 133** despite a **trailing profit margin of only 1.6%** and a **negative revenue growth of 11% YoY** in Q1 2026. The company’s **gross margin has modestly improved to 26%**, yet the overall earnings picture remains weak, highlighted by a **net loss of $0.8 million** and **negative free cash flow**. Technical signals are mixed: the stock sits just above its 20‑day and 50‑day SMAs (1.2655 and 1.2636) but remains far below the 200‑day SMA (1.98), the **MACD histogram is bearish**, and **volume is on a decreasing trend**, suggesting limited buying pressure.
The high **beta of 2.47** and **30‑day volatility exceeding 110%** amplify price swings, while the **consumer defensive sector** offers some defensive cushion but does not offset the company‑specific operational challenges. With **no dividend** and a **debt‑to‑equity ratio over 130**, the balance sheet is strained, and the **max drawdown of 84%** underscores historic downside risk. Investors should weigh the short‑term price weakness against the potential upside from the company’s “Transform & Transcend” restructuring, which aims to lock in a **30% floor for gross margins**.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD and decreasing volume
  • High valuation multiples relative to earnings
  • Continued revenue decline and net loss

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential margin floor from restructuring
  • Improving gross margin despite lower sales
  • Elevated volatility and beta limiting upside

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Strategic shift to higher‑margin products
  • Absence of dividend and high debt load
  • Sector defensive characteristics may provide stability

Key Metrics & Analysis

Financial Health

Revenue Growth-11.40%
Profit Margin1.56%
P/E Ratio133.0
ROE5.88%
ROA0.97%
Debt/Equity131.33
P/B Ratio5.3
Op. Cash Flow$171.0K
Free Cash Flow$-3867000

Technical Analysis

TrendNeutral
RSI53.2
Support$1.10
Resistance$1.41
MA 20$1.27
MA 50$1.26
MA 200$1.98
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta2.47
Volatility116.10%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.